Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.
about
Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future ResearchCationic Polyamidoamine Dendrimers as Modulators of EGFR Signaling In Vitro and In VivoChronic treatment with Ang-(1-7) reverses abnormal reactivity in the corpus cavernosum and normalizes diabetes-induced changes in the protein levels of ACE, ACE2, ROCK1, ROCK2 and omega-hydroxylase in a rat model of type 1 diabetesNonclassical renin-angiotensin system and renal function.Activation of EGFR/ERBB2 via pathways involving ERK1/2, P38 MAPK, AKT and FOXO enhances recovery of diabetic hearts from ischemia-reperfusion injuryTransactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor.Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction.Angiotensin (1-7) prevents angiotensin II-induced nociceptive behaviour via inhibition of p38 MAPK phosphorylation mediated through spinal Mas receptors in mice.RU28318, an aldosterone antagonist, in combination with an ACE inhibitor and angiotensin receptor blocker attenuates cardiac dysfunction in diabetes.New agents modulating the renin-angiotensin-aldosterone system-Will there be a new therapeutic option?Update on the Angiotensin converting enzyme 2-Angiotensin (1-7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways.Angiotensin-(1-7) Downregulates Diabetes-Induced cGMP Phosphodiesterase Activation in Rat Corpus Cavernosum.Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin-angiotensin system.Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications.Modulation of the action of insulin by angiotensin-(1-7).Non-canonical signalling and roles of the vasoactive peptides angiotensins and kinins.Therapeutic implications of peptide interactions with G-protein-coupled receptors in diabetic vasculopathy.The role of epidermal growth factor receptor in diabetes-induced cardiac dysfunction.Src-dependent EGFR transactivation regulates lung inflammation via downstream signaling involving ERK1/2, PI3Kδ/Akt and NFκB induction in a murine asthma model.Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-κB-dependent pathways.Of diabetic mice and ACE2: a new biomarker of renal disease?Effect of a stable Angiotensin-(1-7) analogue on progenitor cell recruitment and cardiovascular function post myocardial infarction.The dual targeting of EGFR and ErbB2 with the inhibitor Lapatinib corrects high glucose-induced apoptosis and vascular dysfunction by opposing multiple diabetes-induced signaling changes.Influence of atorvastatin on angiotensin I metabolism in resting and TNF-α -activated rat vascular smooth muscle cells.
P2860
Q26771727-D00918E7-8BA0-41EC-9469-1AA08A27506BQ28546466-959BF888-3C9C-41E3-AFBE-D62625638F66Q34275725-79359485-1C69-4C2B-BF04-E9DEC213EE7AQ34293723-B0B4BA73-30E7-4634-BE06-F0DEA19E1B4DQ34312113-1E6D6A6C-2D8E-4F4B-A7A1-134EF255AE1DQ34500492-0864465F-95B9-4F70-A1FC-1E3AF2FD5C26Q34797559-5AFC9955-889D-485D-B33A-6A2F631B4D7AQ35148155-0721C94A-0A9F-405D-A55D-B87CA140A40EQ37166553-53F8A9DE-0E7E-4B32-9A66-955CA42941C9Q37347190-112557EB-5A74-4FFE-84C2-04C11DBAA9C3Q37454928-0B91A216-6F06-499C-A368-F3C1E6EB662DQ37680926-9FF7A738-3DE5-4016-B297-ACB3CF7D6266Q38069197-E2E23BB2-1A63-40C5-A855-E29F92911305Q38170474-FAA00840-B902-4415-9EA1-8393EA984359Q38180800-222FAD4E-5DBB-4B61-8A1B-FC24DA164185Q38190099-136C5663-FF28-4AD7-97EA-46371126B7EBQ38196857-7549BD00-814C-4AB6-9DDD-8AF08DBADC51Q40552347-B4F4EA6F-9077-430A-BF0F-F4629509DFCAQ41565956-78DC6100-64E3-43DA-BE96-A32D5C51CF54Q42246428-B4B1B8B0-15FB-4FA6-88BB-C59AEA0F26F3Q42946145-2D46BEA5-8F70-4C41-ACBF-47BE001805CAQ43169811-3CEFCD02-91BE-4521-8145-9486CAD88CA7Q50959754-D5D1851B-C03A-460E-A22B-C391092A2A15Q54272885-5F879BE3-08B2-4FC7-9300-5EC02D8BE93C
P2860
Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Angiotensin-(1-7) inhibits epi ...... as receptor-dependent pathway.
@ast
Angiotensin-(1-7) inhibits epi ...... as receptor-dependent pathway.
@en
type
label
Angiotensin-(1-7) inhibits epi ...... as receptor-dependent pathway.
@ast
Angiotensin-(1-7) inhibits epi ...... as receptor-dependent pathway.
@en
prefLabel
Angiotensin-(1-7) inhibits epi ...... as receptor-dependent pathway.
@ast
Angiotensin-(1-7) inhibits epi ...... as receptor-dependent pathway.
@en
P2093
P2860
P1476
Angiotensin-(1-7) inhibits epi ...... Mas receptor-dependent pathway
@en
P2093
Bindu Chandrasekhar
Gursev S Dhaunsi
Ibrahim F Benter
Omama Al-Farsi
Saghir Akhtar
P2860
P304
P356
10.1111/J.1476-5381.2011.01613.X
P407
P577
2012-03-01T00:00:00Z